|Genomics & Big Data Summit|
Next Generation Sequencing
Big Data Bioinformatics
CRISPR & Genome Engineering
GTCbio’s Big Data Bioinformatics conference provides cutting-edge information on developments in all areas of Bioinformatics research and novel Big Data analytic approaches.
An astonishing volume of biomedical information, ‘big data’, from lab studies, patient records and genomic sequencing are being brought together by life scientists all over the globe. This increasing volume and accessibility of ‘big data’ will provide opportunities for future medical programs in areas like personalized medicine. However ‘big data’ efforts face huge challenges, from creating analytic tools and solving scientific puzzles to accessing millions of gigabytes of data and overcoming barriers to accessing patients’ health records. In order to provide those future opportunities, specific challenges need to be addressed to integrate current discoveries into medical practice.
Through lectures and various discussions, the 2nd Big Data Bioinformatics meeting will assemble leading researchers and experts who will present solutions to some of these challenges.
We hope to see you there!
The 2017 Advisory Committee
Amber Kempf at 626-256-6405 or amber.kempf [at] gtcbio.com
Cancer Genetics Inc. (CGI; Nasdaq: CGIX) is a leader in enabling precision medicine in oncology from bench to bedside through the use of oncology biomarkers and molecular testing. CGI is developing a global footprint with locations in the US, India and China. The Company offers a comprehensive range of laboratory services that provide critical genomic and biomarker information. Its state-of-the-art reference labs are CLIA-certified and CAP-accredited in the US and have licensure from several states including New York State. CGI has established strong clinical research collaborations with major cancer centers such as Memorial Sloan Kettering, The Cleveland Clinic, Mayo Clinic, Keck School of Medicine at USC and the National Cancer Institute.